- Home
- QNCX vs LUMO Comparison
QNCX vs LUMO Comparison
Compare QNCX & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- LUMO
- Stock Information
- Founded
- QNCX 2012
- LUMO 2011
- Country
- QNCX United States
- LUMO United States
- Employees
- QNCX N/A
- LUMO 30
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- QNCX Health Care
- LUMO Health Care
- Exchange
- QNCX Nasdaq
- LUMO Nasdaq
- Market Cap
- QNCX 34.4M
- LUMO 37.4M
- IPO Year
- QNCX 2019
- LUMO N/A
- Fundamental
- Price
- QNCX $2.08
- LUMO $4.33
- Analyst Decision
- QNCX Strong Buy
- LUMO Buy
- Analyst Count
- QNCX 3
- LUMO 4
- Target Price
- QNCX $9.67
- LUMO $9.38
- AVG Volume (30 Days)
- QNCX 1.1M
- LUMO 95.1K
- Earning Date
- QNCX 11-13-2024
- LUMO 11-07-2024
- Dividend Yield
- QNCX N/A
- LUMO N/A
- EPS Growth
- QNCX N/A
- LUMO N/A
- EPS
- QNCX N/A
- LUMO N/A
- Revenue
- QNCX N/A
- LUMO $2,205,000.00
- Revenue This Year
- QNCX N/A
- LUMO $184.11
- Revenue Next Year
- QNCX N/A
- LUMO N/A
- P/E Ratio
- QNCX N/A
- LUMO N/A
- Revenue Growth
- QNCX N/A
- LUMO 26.94
- 52 Week Low
- QNCX $0.51
- LUMO $1.37
- 52 Week High
- QNCX $2.14
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- QNCX 73.91
- LUMO 56.37
- Support Level
- QNCX $1.56
- LUMO $4.30
- Resistance Level
- QNCX $2.14
- LUMO $4.39
- Average True Range (ATR)
- QNCX 0.21
- LUMO 0.08
- MACD
- QNCX 0.02
- LUMO -0.03
- Stochastic Oscillator
- QNCX 91.89
- LUMO 36.36
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.